Q4 / Full Year 2016 Results and
R&D Update 2017
January 25, 2017 in Basel
INVITATION
For those who will not join in person, please find below the dial in details and the link to the webcast:
| Date: | January 25, 2017 | |
| Time: | 13:00 h Switzerland 12:00 h UK 07:00 h New York | |
| Video webcast: | You may access the event as a live video webcast on the internet on January 25, 2017: https://www.novartis.com/investors/event-calendar | |
| Dial-in to conference call: (no possibility to ask questions) | +41 22 592 71 03 | Local - Geneva, Switzerland |
| +44 20 3003 2666 | Local - London, United Kingdom | |
| +1 866 966 5335 | National free phone - USA | |
| +33 1 70 37 71 66 | Local - Paris, France | |
| +49 69 7104 45598 | Local - Frankfurt, Germany | |
| Password: | Novartis | |
| Basel Office | |
| General Phone | +41 61 324 79 44 |
| Samir Shah | +41 61 324 79 44 |
| Pierre-Michel Bringer | +41 61 324 10 65 |
| Thomas Hungerbuehler | +41 61 324 84 25 |
| Isabella Zinck | +41 61 324 71 88 |
| North America Office | |
| Richard Pulik | +1 212 830 24 48 |
| Sloan Pavsner | +1 212 830 24 17 |
| Email: investor.relations@novartis.com www.novartis.com | |
